iodophor

Small moleculeexperimental

An iodophor is a preparation containing iodine complexed with a solubilizing agent, such as a surfactant or water-soluble polymers such as povidone, The result is a water-soluble material that releases free iodine when in solution. — Wikipedia

Clinical trial activity

3 trials · 10 clinical orgs · 0 marketing orgs

Phase 1
0
Phase 2
0
Phase 3
0
Phase 4
3

Earliest trial started Aug 1, 2008 (NCT00739583)

Timeline

No events for the selected filters.

Indications

Approved for

Mechanism of action

Chemistry & pharmacology

Oral

No

Parenteral

No

Topical

No

Sources

Also known as

  • iodophor

Clinical trials

NCT IDPhaseStart dateSponsor(s)
NCT03140423Phase 4May 1, 2017Centers for Disease Control and Prevention (CDC), Harvard University, Hospital Corporation of America, Rush University, University of California, Irvine, University of Massachusetts
NCT03118232Phase 4Apr 3, 2017Department of Health and Human Services, Los Angeles Biomedical Research Institute, University of California, Irvine, University of California, Los Angeles, University of Massachusetts
NCT00739583Phase 4Aug 1, 2008Johns Hopkins University
Showing 3 of 3 trials
Page 1 / 1

Organizations

Research & Development (10)

OrganizationOrg typeTrialsAs lead sponsorPhasesEarliest year
University of California, IrvineAcademic/Hospital2112017
University of MassachusettsAcademic/Hospital2012017
Centers for Disease Control and Prevention (CDC)Government1012017
Department of Health and Human ServicesGovernment1012017
Harvard UniversityAcademic/Hospital1112017
Hospital Corporation of AmericaAcademic/Hospital1012017
Johns Hopkins UniversityAcademic/Hospital1112008
Los Angeles Biomedical Research InstituteAcademic/Hospital1012017
Rush UniversityAcademic/Hospital1012017
University of California, Los AngelesAcademic/Hospital1012017
10 organizations
Page 1 / 1